Abstract: A method of preparing an ester of a carboxylic acid functionalized with a moiety selected from the group consisting of halides, sulfonates, ethers, hydroxyl, amines, and aldehydes, said method comprising: (a) providing either a carboxylic acid having a vinyl group or an ester thereof; (b) functionalizing the vinyl carbon closest to the carboxyl group with said moiety, wherein said functionalizing comprises cleaving said vinyl group.

Abstract: This invention relates to a novel polycarbonate-based block polymer, and to fibers and bioresorbable implantable medical devices fabricated from said fibers.

Abstract: This invention relates to medical devices formed totally or in part from homopolymers or copolymers comprising recurring carbonate moieties.

Abstract: This invention relates to medical devices formed totally or in part from homopolymers or copolymers comprising recurring carbonate moieties.

Abstract: This invention relates to medical devices formed totally or in part from homopolymers or copolymers comprising recurring carbonate moieties.

Abstract: This invention relates to medical devices formed totally or in part from homopolymers or copolymers comprising recurring carbonate moieties.

Abstract: This invention relates to novel copolymers containing carbonate repeat units and ester repeat units.

Abstract: This invention relates to medical devices formed totally or in part from homopolymers or copolymers comprising recurring carbonate moieties.

Abstract: This invention relates to medical devices formed totally or in part from homopolymers or copolymers comprising recurring carbonate moieties.

Abstract: This invention relates to a novel polycarbonate-based block polymer, and to fibers and bioresorbable implantable medical devices fabricated from said fibers.

Abstract: This invention relates to novel copolymers containing carbonate repeat units and ester repeat units.

Abstract: This invention relates to medical devices formed totally or in part from homopolymers or copolymers comprising recurring carbonate moieties.

Abstract: This invention relates to novel copolymers containing carbonate repeat units and ester repeat units.

Abstract: Novel polycarbonate homopolymers and implantable bioresorbable medical devices fabricated therefrom.

Abstract: This invention is directed to novel random copolymers and implantable devices fabricated therefrom.

Abstract: Polymer-bound alkyl diarylphosphinite catalyst compositions having the formula I: ##STR1## wherein the trivalent phosphorus is substituted by one alkoxy group and one aryl group and wherein the third bond of phosphorus is a P-C bond to a pendant aryl groups of the polymer matrix and wherein .circle.p --C.sub.6 H.sub.4 -- is a polymer matrix containing aromatic groups such as polystyrene cross-linked with divinylbenzene and wherein at least 1% of pendant aryl groups of the polymer matrix are bound to phosphorus and wherein Ar is substituted by electron-donating groups such as alkyl, alkoxy, and N,N-dialkylamino, are disclosed. Polymer-bound aryl dialkyl phosphonites having the formula II, .circle.p --C.sub.6 H.sub.4 --P(OR).sub.2 and polymer-bound diarylphosphinous chlorides having the formula .circle.p --C.sub.6 H.sub.4 --P--(Ar')--Cl are also disclosed. Processes for making the polymer-bound phosphinites, phosphonites and phosphinous chlorides are also disclosed.

Abstract: Selective conversion of acrylonitrile into 1,4-dicyano-1-butene by contacting a liquid phase comprising acrylonitrile with an effective amount of a polymer-bound alkyl diarylphosphinite catalyst having the formula I: ##STR1## wherein the trivalent phosphorus is substituted by one alkoxy group and one aryl group and wherein the third bond of phosphorus is a P--C bond to a pendant aryl group of the polymer matrix, such as polystyrene cross-linked with divinylbenzene is disclosed. Treatment of the liquid phase, prior to contacting same with the polymer-bound catalyst, with a drying agent comprising a polymer-bound dialkyl arylphosphonite and regeneration of the drying agent are also disclosed.

Abstract: Polymer-bound alkyl diarylphosphinite catalyst compositions having the formula I: ##STR1## wherein the trivalent phosphorus is substituted by one alkoxy group and one aryl group and wherein the third bond of phosphorus is a P--C bond to a pendant aryl groups of the polymer matrix and wherein .circle.p --C.sub.6 H.sub.4 -- is a polymer matrix containing aromatic groups such as polystyrene cross-linked with divinylbenzene and wherein at least 1% of pendant aryl groups of the polymer matrix are bound to phosphorus and wherein Ar is substituted by electron-donating groups such as alkyl, alkoxy, and N,N-dialkylamino, are disclosed. Polymer-bound aryl dialkyl phosphonites having the formula II, .circle.p --C.sub.6 H.sub.4 --P(OR).sub.2 and polymer-bound diarylphosphinous chlorides having the formula .circle.p --C.sub.6 H.sub.4 --P--(Ar')--Cl are also disclosed. Processes for making the polymer-bound phosphinites, phosphonites and phosphinous chlorides are also disclosed.

Abstract: Selective conversion of acrylonitrile into 1,4-dicyano-1-butene by contacting a liquid phase comprising acrylonitrile with an effective amount of a polymer-bound alkyl diarylphosphinite catalyst having the formula I: ##STR1## wherein the trivalent phosphorus is substituted by one alkoxy group and one aryl group and wherein the third bond of phosphorus is a P--C bond to a pendant aryl group of the polymer matrix, such as polystyrene cross-linked with divinylbenzene is disclosed. Treatment of the liquid phase, prior to contacting same with the polymer-bound catalyst, with a drying agent comprising a polymer-bound dialkyl arylphosphonite and regeneration of the drying agent are also disclosed.

Abstract: A racemic mixture of D- and L- forms of alpha-aminocaprolactam ("ACL") dissolved in e.g. ethanol is resolved, and preferably the undesired form remaining is solution is simultaneously racemized, by forming a supersaturated solution of the D,L-(ACL).sub.3 NiCl.sub.2. EtOH complex; providing an optically active form of lysine (e.g. L-lysine) as crystallization inhibitor of the undesired enantiomer of said complex (e.g. the D-form), and crystallizing a portion of the desired form of the complex from the solution. The undesired form remaining in solution can be simultaneously racemized by providing a strong base and an excess of ACL over the stoichiometric proportion required to form the complex. The recovered crystals of the desired form of the complex can be processed to afford the desired form of ACL, and to recover the nickel reagent. The ACL can be converted to the desired form of lysine, a nutritionally valuable amino acid.